Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 72.34M | 75.05M | 74.75M | 74.33M | 72.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.34M | 75.05M | 74.75M | 74.33M | 72.50M |
| Cost of Revenue | 18.41M | 18.99M | 20.17M | 20.73M | 20.67M |
| Gross Profit | 53.93M | 56.06M | 54.58M | 53.60M | 51.83M |
| SG&A Expenses | 40.62M | 40.54M | 41.53M | 42.62M | 52.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.60M | 82.68M | 87.19M | 89.90M | 101.84M |
| Operating Income | -8.26M | -7.63M | -12.44M | -15.57M | -29.34M |
| Income Before Tax | -8.16M | -7.49M | -16.01M | -18.66M | -32.25M |
| Income Tax Expenses | 220.40K | 217.70K | 832.80K | 831.30K | 823.80K |
| Earnings from Continuing Operations | -8.38 | -7.71 | -16.84 | -19.49 | -33.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.38M | -7.71M | -16.84M | -19.49M | -33.07M |
| EBIT | -8.26M | -7.63M | -12.44M | -15.57M | -29.34M |
| EBITDA | -3.15M | -1.53M | -5.31M | -5.65M | -16.66M |
| EPS Basic | -7.89 | -7.22 | -16.08 | -18.74 | -32.04 |
| Normalized Basic EPS | -0.40 | -0.36 | -0.58 | -0.75 | -0.75 |
| EPS Diluted | -7.89 | -7.22 | -16.08 | -18.74 | -32.04 |
| Normalized Diluted EPS | -0.40 | -0.36 | -0.58 | -0.75 | -0.75 |
| Average Basic Shares Outstanding | 42.54M | 42.78M | 42.64M | 42.19M | 41.68M |
| Average Diluted Shares Outstanding | 4.25M | 4.28M | 4.26M | 4.22M | 4.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |